Congresses

Title Yearsort ascending
Mathematical model of meropenem against Mycobacterium tuberculosis 2019
ESTUDIOS DE ELUCIDACIÓN DEL MODO DE ACCIÓN DE LAS AVERMECTINAS FRENTE A MYCOBACTERIUM 2019
Mode of action elucidation studies of the avermectins against Mycobacteria 2019
DEVELOPMENT OF A HIGH-THROUGHPUT METHOD FOR SYNERGISTIC DRUG COMBINATIONS SCREENING 2019
Beta-lactams for Tuberculosis Treatment 2019
Mode of action elucidation studies of a new chemical series active against Mycobacteria and other microbial pathogens 2019
TOWARDS THE ELUCIDATION OF THE MODE OF ACTION OF A NEW CHEMICAL SERIES WITH ANTIMICROBIAL ACTIVITY 2019
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening 2019
A novel methodology to identify synergistic drug combinations against non-tuberculous mycobacteria in cystic fibrosis 2019
Towards efficient in vitro screening tools to discover new clinical options in the treatment of non-tuberculous Mycobacteria 2019
PRELIMINARY STUDIES FOR THE ELUCIDATION OF THE MODE OF ACTION OF THE AVERMECTINS AS ANTI-TB AGENTS 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
In vitro profiling of anthelmintic avermectins against non-tuberculous mycobacteria 2019
Sanfetrinem, repurposing an oral beta-lactam with intracellular activity for the treatment of tuberculosis 2019
Nuevos métodos para la búsqueda de combinaciones sinérgicas 2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria 2019
New methodologies to test antibiotic susceptibility against emerging pathogens in cystic fibrosis 2019
Repurposing beta-lactams for buruli ulcer treatment 2018
REPURPOSING BETA-LACTAMS FOR BURULI ULCER TREATMENT 2018
Preliminary studies to elucidate the mode of action of a new chemical series with antimicrobial activity 2018

Pages